Upload File

supplement 1: care of the sars-cov-2 positive patient in

  • Home
  • Documents
  • Supplement 1: Care of the SARS-CoV-2 Positive Patient in
6
Supplement 1: Care of the SARS-CoV-2 Positive Patient in Neurointensive Care - 2020 COVID-19 Pandemic Initial Action Cards for Staff Working in Neurosurgical and Neuromedical Intensive Care

Upload: others

Post on 16-Oct-2021

2 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: Supplement 1: Care of the SARS-CoV-2 Positive Patient in

Supplement 1: Care of the SARS-CoV-2 Positive Patient in Neurointensive Care - 2020

COVID-19 Pandemic Initial Action Cards for Staff Working in Neurosurgical and Neuromedical Intensive Care

Page 2: Supplement 1: Care of the SARS-CoV-2 Positive Patient in
Page 3: Supplement 1: Care of the SARS-CoV-2 Positive Patient in
Page 4: Supplement 1: Care of the SARS-CoV-2 Positive Patient in
Page 5: Supplement 1: Care of the SARS-CoV-2 Positive Patient in
Page 6: Supplement 1: Care of the SARS-CoV-2 Positive Patient in

RocketVax: SARS-CoV-2 vaccine development

Recombinant SARS-CoV-2 Nucleocapsid Protein (Full Length ... of SARS-CoV-2 Pseudovirus (… · PSV01) is recombinant pseudotyped lentiviral particles containing SARS-CoV-2 spike protein

SARS-CoV-2AntigenTestKit(LFIA

Research Paper environment modulation in pneumonia patients caused by SARS-CoV… · 2020-05-15 · CoV, MERS-CoV and SARS-CoV-2 SARS-CoV-2 shows 88% identity to the sequence of SARS-like

SARS-CoV-2 in Australia

TaqMan SARS-CoV-2 Mutation Panel

SARS-CoV-2 and ORF3a: Nonsynonymous …SARS-CoV-2, RaTG13, and pangolin CoV. A D173Y substitution was detected in one SARS-CoV-2 strain (EPI_ISL_419177; source, France; date, 22 March

SARS-CoV-2 - WHO

 · that antibodies to SARS-CoV-2 were detected, and the individual has potentially been exposed to SARS-CoV-2. Antibodies to SARS-CoV-2 are generally detectable several days following

FTD SARS-CoV-2 Assay

cobas SARS-CoV-2 Test For detection of SARS-CoV-2 · cobas® SARS-CoV-2 Test For detection of SARS-CoV-2 SARS-CoV-2 is a novel respiratory coronavirus that can cause severe pneumonia

Innate Immune Responses Against Corona virus Infection...Title: SARS-CoV-2 (COVID-19) poster Author: GeneTex Subject: SARS-CoV-2 \(COVID-19\) poster Keywords: SARS-CoV-2 (COVID-19)

Blueprint for a pop-up SARS-CoV-2 testing lab - …correspondence. 3 SARS-CoV-2 + + + S

transmission of SARS-CoV-2

SARS-like WIV1-CoV poised for human emergencesaigaiin.sakura.ne.jp/sblo_files/saigaiin/image/SARS-like20WIV1... · SARS-like WIV1-CoV poised for human emergence ... surveillance beyond

An Immunological Outlook on SARS Coronavirus (SARS-CoV-2

Lyra SARS-CoV-2 Assay Lyra Direct SARS-CoV-2 Assay

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An

The roles of signaling pathways in SARS-CoV-2 infection ......The roles of signaling pathways in SARS‑CoV‑2 infection; lessons learned from SARS‑CoV and MERS‑CoV NimaHemmat

SARS-CoV-2 ORF1ab and N genes...SARS-CoV and MERS-CoV have caused more than 10,000 cumulative cases in the past two decades, with mortality rates of 34% MERS-CoV and 10% SARS-CoV

Contact based transmission of SARS-CoV-2 · Title Contact based transmission of SARS-CoV-2 Norwegian title Kontaktsmitte av SARS-CoV-2 Institution Norwegian Institute of Public Health

Computational analysis of SARS- CoV-2, SARS-CoV, and MERS

Xpert Xpress SARS-CoV-2

SARS-CoV-2 Genes - MDPI

Serological diagnostic kit of SARS-CoV-2 antibodies using ......2020/03/26  · 28 Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-29 expressed full-length SARS-CoV-2

Theeecofcoonaiinfecion (SARS-CoV-2,MERS -CoV,andSARS -CoV

Xpert Xpress SARS-CoV-2/Flu/RSV Verification Guide Xpress SARS-CoV-2...2010/12/22  · Xpert ® Xpress SARS-CoV-2/Flu/RSV Verification Guide 4 Run a positive control for SARS-CoV-2,

Minimal system for assembly of SARS-CoV-2 virus like particles · 6/1/2020  · Given the similarities between SARS-CoV-2 and SARS-CoV viruses 1, 12, we set out to create SARS-CoV-2

SARS-CoV-2 Surveillance

Household Transmission of SARS-CoV-2: A Systematic Review … · Figure1.SecondaryAttackRates(SAR)ofSevereAcuteRespiratorySyndromeCoronavirus2(SARS-CoV-2)forHouseholdContactsandFamilyContacts

SARS-COV-2 ANTIVIRAL THERAPEUTICS · 2021. 1. 19. · vaccinedevelopment investigation. The SARS (caused by SARS-CoV-1) and MERS (Middle East Respiratory Syndrome, caused by MERS-CoV)

SARS-CoV-2 (2019-nCoV) Nucleoprotein / NP ELISA Kit · SARS-CoV-2 (2019-nCoV) Nucleoprotein / NP Standard - Recombinant SARS-CoV-2 (2019-nCoV) Nucleoprotein / NP in a buffer with

Transport of suspected and confirmed (MERS, SARS, SARS-CoV ...€¦ · Transport of suspected and confirmed (MERS, SARS, SARS-CoV-2 or Novel Coronavirus) Transport of a patient Document

SARS-CoV-2 Antibody Profiling

SARS-CoV-2 genome evolution exposes early human adaptations · 2020. 5. 26. · Title: SARS-CoV-2 genome evolution exposes early human adaptations Running title: SARS-CoV-2 routes